The Influenza Diagnostic Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Influenza Diagnostic Market?
The global influenza diagnostic market has seen considerable expansion in recent years. The market size surged from $2.73 billion in 2024 to $2.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Influenza Diagnostic Industry?
The Influenza Diagnostic Global Market Report 2025 predicts a market size of $4.01 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%.
Download Your Free Sample of the 2025 Influenza Diagnostic Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Influenza Diagnostic Market?
The key drivers in the influenza diagnostic market are:
• Rising demand for customization and scalability in diagnostic procedures
• Increasing commitment towards environmental sustainability and health goals
• The growing need to enhance operational efficiency in diagnosis and treatment
• Necessity to keep up with the changing dynamics of the modern medical supply chain
Global Market Segmentation: Identifying Major Influenza Diagnostic Industry Segments
The influenza diagnostic market covered in this report is segmented –
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
Pre-order the 2025 Influenza Diagnostic Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Influenza Diagnostic Market?
The key trends in the influenza diagnostic market are:
• Advanced technology integration is a prominent emerging trend.
• The use of robotic picking and packing is gaining momentum.
• Autonomous mobile robots are becoming increasingly popular in the influenza diagnostic market.
• Real-time data and analytics are increasingly influencing the industry's future growth.
Who Are the Top Competitors & Leading Players in the Influenza Diagnostic Market?
Major companies in the influenza diagnostic market are:
• F. Hoffmann-La Roche Ltd.
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Hologic Inc.
• Becton Dickinson and Company
• DiaSorin SpA
• Luminex Corporation
• Meridian Bioscience Inc.
• GenMark Diagnostics Inc.
• SA Scientific Ltd.
• Sekisui Diagnostics LLC
• bioMérieux Inc.
• Danaher Corporation
• Siemens Healthineers AG
• Coris Bioconcept Sprl
• Mast Group
• Elitech Technology lnc.
• Analytik Jena AG
• altona Diagnostics GmbH
• Tecan Trading AG
• Genome Diagnostics Pvt Ltd.
• Germaine Laboratories Inc.
• Response Biomedical Corporation
• TAUNS Laboratories Inc.
• TRUPCR Europe Ltd.
• Quest Diagnostics Inc.
• Labcorp Employer Services Inc.
• TotalWellness Ltd.
• Health Advocate Inc.
• Optum Global Solutions Private Ltd.
Regional Dominance: Which Area Leads the Global Influenza Diagnostic Market?
North America was the largest region in the influenza diagnostics market in 2023
